Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose decitabine with or without valproic acid and ATRA in elderly AML ineligible for induction chemotherapy
DRKS00000733Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of decitabine, valproic acid and tretinoin in acute myeloid leukemia (AML) (4 arms), sponsored by Universitätsklinikum Freiburg. Started Apr 2011; status: completed.
02
Drugs
decitabinevalproic acidtretinoin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on DRKS00000733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000733.